Yun-Long Li,Wenqing Yao,Andrew P. Combs,Eddy W. Yue,Song Mei,Joseph Glenn,Thomas P. Maduskuie, Jr.,Richard B. Sparks,Brent Douty,Chunhong He
申请号：
US16828315
公开号：
US20200323858A1
申请日:
2020.03.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides heterocyclylamine derivatives of Formula I:wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
